Imaging of Coronary Plaques in Participants Treated With Evolocumab

Clinical trial NCT03570697 · COMPLETED

Trial details

NCT number: NCT03570697
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease (CAD)

Start date: 2018-11-19
Primary completion: 2020-12-18
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.